Michael Taylor made the move to trading the stock market with his own capital on a full time basis in December 2016. As well as ShareScope, Michael contributes to Investors Chronicle and other online publications. He has also written a free book on getting started in the UK stock market, along with a stock trading handbook – both of which are available to download from his website at www.shiftingshares.com
I believe that anyone can learn to trade if they are able to remain objective and are willing to put the hours in. I lost a lot of money early on by not having a proper strategy and following the crowd. If you want to make money then you need to generate your own ideas – I use SharePad to find and plan my trades, and ShareScope to run on my trading screens.
Breakouts are an excellent way to swing trade and profit from bull markets. I love breakouts because they’re a high probability pattern of continuation and also because it means that the price is rising. However, many people try strategies that that are inherently risky. Sadly, one private investor commented that they’d invested into a stock
We looked at two potential stage 2 stocks a few weeks ago here. The issue with some AIM stocks is that they don’t offer the liquidity that some traders prefer. In this article, we’ll look at some FTSE miners that trade on both the FTSE 100 and FTSE 250 indices. These stocks are traded in
I was at lunch this week with some trader friends, discussing the market and the various strategies you can use to make money. We came to the agreement that in the small caps space, having an informational edge is definitely an advantage. Knowing what you own and why you own it is one of Peter
The market has been risk-off in the last few weeks. Why? It’s anyone’s guess. The Talking Heads will say inflation, price of lumber rising, price of lumber falling, geopolitical tensions… If only they could tell us before the event instead of finding reasons for why things happened after the event.
April is typically a strong month – perhaps because of all the tax-selling clearing and reducing sell pressure. New ISA money tends to enter the market too. Cash is a position, but many punters feel it burning a hole in their pockets and so tend to end up spending it.
I run my filter every week, usually on a Saturday morning. By running the filter every week, it allows five trading sessions to pass and therefore potentially offer up new stocks. Time is a trader’s greatest asset, and it makes no sense to run the filter every day when almost all of the stocks will be the same.
A few months ago, SharePad released a new feature called the Single Page. Learn to use it and maximise your productivity.
The breakout retest is a great way of trading a breakout if you missed the initial rally. We looked at how traders should look to play these and the importance of a well-timed buy.
Everyone likes a turnaround. This is because people like the idea of buying at the bottom and reaping the rewards.
However, trading turnarounds can take a lot of time. Businesses are often slow to change and it is not a quick process.
This article will show you how to trade some potential turnaround stocks and give you some pointers to look at next time you are considering trading a turnaround.
My last article detailed my new filter. If you missed it then you can read about it here. As discussed, this filter looks for stocks that are uptrending and are off their recent highs. It provides trading ideas that we can then dig further into. Here are some recent results. Calnex Solutions (CLX) Calnex is
I released a new filter several weeks ago. This was a new filter I was testing and mentioned this in my Investors Chronicle column. I’ve released it onto the library due to popular demand and in this article I’ll explain how to get the best out of this filter. First of all, you can find
The pharmaceuticals sector is another popular sector with private investors and retail traders. This is because the volatility is high and traders are often attracted to the blue-sky lottery ticket type stocks. The road for a junior pharmaceutical company is long and hard. First of all, drugs need to go through three phases of testing